RPTX Stock Summary and Trading Ideas (Repare Therapeutics - Common Shares | NASDAQ:RPTX)

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.

Repare Therapeutics - Common Shares trades on the NASDAQ stock market under the symbol RPTX.

As of December 26, 2025, RPTX stock price climbed to $2.57 with 702,892 million shares trading.

RPTX has a beta of 0.37, meaning it tends to be less sensitive to market movements. RPTX has a correlation of 0.01 to the broad based SPY ETF.

RPTX has a market cap of $110.41 million. This is considered a Micro Cap stock.

Last quarter Repare Therapeutics - Common Shares reported $12 million in Revenue and $.08 earnings per share. This beat revenue expectation by $7 million and exceeded earnings estimates by $.40.

In the last 3 years, RPTX traded as high as $15.38 and as low as $.89.

The top ETF exchange traded funds that RPTX belongs to (by Net Assets): AVSC.

RPTX has outperformed the market in the last year with a price return of +94.7% while the SPY ETF gained +16.0%. RPTX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +52.1% and +20.1%, respectively, while the SPY returned +4.6% and +1.5%, respectively.

RPTX support price is $2.48 and resistance is $2.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that RPTX shares will trade within this expected range on the day.